Methyl 1-methoxy-4-oxocyclohexane-1-carboxylate, 95%, 10g

ac-dl-met-oh, 98%, 500g

4-Benzyloxyphenylacetic acid, 98.0%, 1g

4-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)benzoic acid, 95.0%, 25mg

4-(4-Methoxyphenyl)thiazol-2-ylamine, 95.0%, 1g

(S)-6-Bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 98%, 50mg

1,3,5-Trimethoxybenzene, 95.0%, 10g

4-((Benzyloxy)carbonyl)morpholine-2-carboxylic acid, 97%, 10g

6-CHLORO-3-METHYL-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-8-AMINE, 95.0%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-3-(2,4,5-trifluorophenyl)propanoic acid, 95.0%, 1g

4-CYANO-3,5-DIMETHYLBENZOIC ACID, 95.0%, 100mg

Colonne capillaire GC ROTI®Cap-5 MS Ultra, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

(2S,5S)-(-)-5-BENZYL-3-METHYL-2-(5-METHYL-2-FURYL)-4-IMIDAZOLIDINONE, 95%, 250mg